[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Zhang et al., 2002 - Google Patents

Novel, potent ORL-1 receptor agonist peptides containing α-helix-promoting conformational constraints

Zhang et al., 2002

View PDF
Document ID
17538348184509010777
Author
Zhang C
Miller W
Valenzano K
Kyle D
Publication year
Publication venue
Journal of medicinal chemistry

External Links

Snippet

The ORL-1 receptor has recently been cloned and is implicated in a wide variety of physiological and pathophysiological processes. Toward the goal of elucidating important features of the receptor-bound conformation of the endogenous ligand, nociceptin (NC) …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

Similar Documents

Publication Publication Date Title
Zhang et al. Novel, potent ORL-1 receptor agonist peptides containing α-helix-promoting conformational constraints
Jackson et al. Design, pharmacology, and NMR structure of a minimized cystine knot with agouti-related protein activity
Li et al. Constitutive activation of the μ opioid receptor by mutation of D3. 49 (164), but not D3. 32 (147): D3. 49 (164) is critical for stabilization of the inactive form of the receptor and for its expression
Wilczynski et al. Identification of putative agouti-related protein (87− 132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands
McNulty et al. High-resolution NMR structure of the chemically-synthesized melanocortin receptor binding domain AGRP (87− 132) of the agouti-related protein
Murray et al. Single residue substitutions that confer voltage-gated sodium ion channel subtype selectivity in the NaV1. 7 inhibitory peptide GpTx-1
Grieco et al. A new, potent urotensin II receptor peptide agonist containing a Pen residue at the disulfide bridge
Beyermann et al. A single-point slight alteration set as a tool for structure− activity relationship studies of ovine corticotropin releasing factor
Yamamoto et al. Design, synthesis, and biological evaluation of novel bifunctional C-terminal-modified peptides for δ/μ opioid receptor agonists and neurokinin-1 receptor antagonists
Takayama et al. Discovery of selective hexapeptide agonists to human neuromedin U receptors types 1 and 2
Agnes et al. Structure− activity relationships of bifunctional peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors
Křížková et al. Insulin–insulin-like growth factors hybrids as molecular probes of hormone: receptor binding specificity
Østergaard et al. Design of Y2 receptor selective and proteolytically stable PYY3–36 analogues
Ericson et al. Discovery of a β-hairpin octapeptide, c [Pro-Arg-Phe-Phe-Dap-Ala-Phe-DPro], mimetic of agouti-related protein (87–132)[AGRP (87–132)] with equipotent mouse melanocortin-4 receptor (mMC4R) antagonist pharmacology
Bennett et al. Identification of arodyn, a novel acetylated dynorphin A-(1− 11) analogue, as a κ opioid receptor antagonist
Carotenuto et al. Lead optimization of P5U and urantide: discovery of novel potent ligands at the urotensin-II receptor
Reynaud et al. A venomics approach coupled to high-throughput toxin production strategies identifies the first venom-derived melanocortin receptor agonists
Doering et al. Melanocortin antagonist tetrapeptides with minimal agonist activity at the mouse melanocortin-3 receptor
Xu et al. Mutagenesis and computational modeling of human G-protein-coupled receptor Y2 for neuropeptide Y and peptide YY
Fleming et al. Structure–Activity Relationship Studies of a Macrocyclic AGRP-Mimetic Scaffold c [Pro-Arg-Phe-Phe-Asn-Ala-Phe-DPro] Yield Potent and Selective Melanocortin-4 Receptor Antagonists and Melanocortin-5 Receptor Inverse Agonists That Increase Food Intake in Mice
Archer-Lahlou et al. Modeled structure of a G-protein-coupled receptor: the cholecystokinin-1 receptor
Konieczny et al. Oligopeptides as neuropeptide Y Y4 receptor ligands: identification of a high-affinity tetrapeptide agonist and a hexapeptide antagonist
Fleming et al. Synergistic multiresidue substitutions of a macrocyclic c [Pro-Arg-Phe-Phe-Asn-Ala-Phe-DPro] agouti-related protein (AGRP) scaffold yield potent and> 600-fold MC4R versus MC3R selective melanocortin receptor antagonists
Harrison et al. Novel helix-constrained nociceptin derivatives are potent agonists and antagonists of ERK phosphorylation and thermal analgesia in mice
Noh et al. Analysis of amylin consensus sequences suggests that human amylin is not optimized to minimize amyloid formation and provides clues to factors that modulate amyloidogenicity